Last reviewed · How we verify
NCT07234786
Clinical Study of a Vaginal Gel for the Treatment and Prevention of Vaginal Infections
NA trial testing Multi-Gyn FemiTotal in Bacterial Vaginosis in 80 participants. Currently enrolling.
31 December 2026
Quick facts
| Lead sponsor | Karo Pharma AB |
|---|---|
| Phase | NA |
| Status | Recruiting now |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 80 |
| Start date | 20 October 2025 |
| Primary completion | 31 December 2026 |
| Estimated completion | 31 March 2027 |
| Sites | 1 location across Mauritius |
Drugs / interventions tested
- Multi-Gyn FemiTotal
Conditions studied
- Bacterial Vaginosis — all drugs for Bacterial Vaginosis →
- Vaginal Candidiasis — all drugs for Vaginal Candidiasis →
Sponsor
Karo Pharma AB
Who can join
18 and older, female only, with Bacterial Vaginosis or Vaginal Candidiasis. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The goal of this clinical trial is to assess the safety and efficacy of Multi-Gyn Femitotal to treat and prevent women suffering from bacterial vaginosis and vulvo vaginal candidiasis. 40 subjects with itching symptoms of VVC and 49 subjects with BV as confirmed using Amsel criteria will be included and will use the device for 7 days (treatment phase). If the VVC symptoms and BV are considered as cured 21 days after the beginning of treatment, the subjects will be followed-up until Month 4 after treatment initiation to check the re-occurrence of VVC and BV (prevention phase).The primary objective is to evaluate the effectiveness of Multi-Gyn FemiTotal for the treatment of Bacterial Vaginosis (BV) and relief of VulvoVaginal Candidiasis (VVC) itching, 21 days after treatment initiation.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07234786
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Bacterial Vaginosis
Currently open trials in the same condition.
- NCT06458543 — Optimization of Bacterial Vaginosis Treatment in Women of Reproductive Age · Phase 4 · recruiting
- NCT06263465 — Precision Vaginal Microbiome Transplantation in Women With Bacterial Vaginosis · NA · recruiting
- NCT05753813 — Exploring the Effects of an Intravaginal Lactic Acid Gel on the Vaginal Microbiome · EARLY_PHASE1 · recruiting
- NCT06616168 — Urogenital Infections in Women of Reproductive Age and the Activity of 4-Thiazolidinone Derivatives Against Pathogens · Phase 1 · active not recruiting
- NCT05666778 — Single Arm Trial of Menstrual Cups Among Economically Vulnerable Women to Reduce Bacterial Vaginosis and STIs · Phase 2 · active not recruiting
Other Karo Pharma AB trials
Trials by the same sponsor.
- NCT07233473 — Evaluation of the Effectiveness and Safety of a Vaginal Gel for Prevention of Recurrent Urinary Tract Infections · NA · recruiting
- NCT05552378 — Multi-Gyn FloraFem Study for Treatment of Vulvo Vaginal Candidiasis Symptoms · NA · completed
- NCT05732337 — Open Clinical Investigation to Evaluate the Effectiveness and Safety of a Topical Medical Device. · NA · completed
- NCT05560841 — Effectiveness and Safety of Nailner Brush 2in1 in Onychomycosis · NA · completed
- NCT05211921 — Single Arm Study of Multi-Gyn ActiGel Plus for Treatment of Bacterial Vaginosis · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07234786 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Karo Pharma AB
- Last refreshed: 18 November 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07234786.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing